About this episode
Dustin Robinson is the Managing Principal of Iter Investments and their venture studio Nucleus.
He has a background in law and has advised and invested in numerous companies across the cannabis and psychedelics space. On today's podcast, we learn what Dustin and the Iter team look for in a company before investing, why they've decided to launch a crowdfunding campaign for their data-driven Nucleus platform, and why he's still bullish on investing in the psychedelic space despite the poor performance of the market sector over the last year.
Please consider rating, reviewing, and sharing the podcast wherever you're listening
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Mycopreneur publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Mycopreneur
Lee Carroll: Ergothioneine in Support of Psychedelic Therapy
Mycopreneur
Adam Miezio: Psychedelics in the Epstein Files
Mycopreneur
Robert Gallery: Ibogaine For Athletes with Traumatic Brain Injuries
Mycopreneur
Melanie Tremblay: The Hidden Dangers of AI-Generated Mushroom Claims
Mycopreneur